{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:41:11Z","timestamp":1774273271604,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1023\/a:1018854906444","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T16:23:59Z","timestamp":1045671839000},"page":"529-533","source":"Crossref","is-referenced-by-count":50,"title":["Case Report: Dramatic Resolution of Skin Lesions Associated with Porphyria Cutanea Tarda After Interferon-\u03b1 Therapy in a Case of Chronic Hepatitis C"],"prefix":"10.1007","volume":"43","author":[{"given":"M. Yasin","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti B.","family":"Burruss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"294547_CR1","first-page":"55","volume-title":"Recent Advances in Dermatology","author":"GH Elder","year":"1990","unstructured":"Elder GH: Porphyria cutania tarda: A multifactorial disease. InRecent Advances in Dermatology, Volume 8. RH Campion, RJ Pye (eds). Edinburgh, Churchill-Livingstone, 1990, pp 55\u201369"},{"key":"294547_CR2","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","volume":"16","author":"S Fargion","year":"1992","unstructured":"Fargion S, Piperno A, Capellini MD, Sampiertr M, Fracanzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi L, Fiorelli G: Hepatitis C virus and porphyria cutanea tarda: Evidence of strong association. Hepatology 16:1322\u20131326, 1992","journal-title":"Hepatology"},{"key":"294547_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hep.1840170405","volume":"17","author":"M DeCastro","year":"1993","unstructured":"DeCastro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Bue y L, Garcia-Monzon C, Sequi J, Moreno-Otero R: Hepatitis C antibodies and liver disease in patients with por phyria cutanea tarda. Hepatology 17:551\u2013557, 1993","journal-title":"Hepatology"},{"key":"294547_CR4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2133.1993.tb15139.x","volume":"128","author":"JP Lacour","year":"1993","unstructured":"Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP: Por phyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 128:121\u2013123, 1993","journal-title":"Br J Dermatol"},{"key":"294547_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/0140-6736(93)90562-U","volume":"341","author":"C Herrero","year":"1993","unstructured":"Herrero C, Vincente A, Bruguera M, Ercilla S, Barrera JM, Vidal J, Teres J, Mascaro JM, Rodes J: Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lance t 341:788\u2013789, 1993","journal-title":"Lance t"},{"key":"294547_CR6","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/0140-6736(93)90670-C","volume":"341","author":"A Murphy","year":"1993","unstructured":"Murphy A, Dooley S, Hillary IB, Murphy GM: HCV infection in porphyria cutanea tarda. Lancet 341:1534\u20131535, 1993","journal-title":"Lancet"},{"key":"294547_CR7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","volume":"321","author":"GL Davis","year":"1989","unstructured":"Davis GL, Balart LA, Schiff ER, Linsday K, Bodenheimer H, Perillo R, Carey W, Jacobson IM, Payne J, Dienstag JL, VanThiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A: Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized, controlled trial. N Engl J Med 321:1501\u20131506, 1989","journal-title":"N Engl J Med"},{"key":"294547_CR8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7326\/0003-4819-115-9-700","volume":"115","author":"M Shindo","year":"1991","unstructured":"Shindo M, Di Bisceglie A, Cheung L, Wai-Kuo Shih J, Cris tiano K, Feinstone S, Hoofnagle J: Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 115:700\u2013704, 1991","journal-title":"Ann Intern Med"},{"key":"294547_CR9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/0270-9139(95)90234-1","volume":"21","author":"O Reichard","year":"1995","unstructured":"Reichard O, Glaumann H, Fryden A, Norkrans G, Schvarcz R, Sonnerborg A, Zhi-Bing Y, Weiland O: Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alpha-2b treatment. Hepatology 21:916\u2013922, 1995","journal-title":"Hepatology"},{"key":"294547_CR10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-121-4-199408150-00018","volume":"121","author":"LB Siegel","year":"1994","unstructured":"Siegel LB, Eber BB: Porphyria cutanea tarda remission. Ann Intern Med 121:304\u2013309, 1994 ( letter)","journal-title":"Ann Intern Med"},{"key":"294547_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0168-8278(95)80438-2","volume":"22","author":"H Takikawa","year":"1995","unstructured":"Takikawa H, Yamazaki R, Shoji S, Miyake K, Yamanaka M: Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda. J Hepatol 22:249\u2013250, 1995","journal-title":"J Hepatol"},{"key":"294547_CR12","first-page":"1148","volume":"18","author":"D Grasset","year":"1994","unstructured":"Grasset D, Nougue J, Seigneuric C, Landreaud M, Voigt JJ: Porphyria cutanea tarda and chronic hepatitis C. Course after interferon therapy. Gastroenterol Clin Biol 18:1148\u20131149, 1994 (letter)","journal-title":"Gastroenterol Clin Biol"},{"key":"294547_CR13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1099\/0022-1317-73-3-673","volume":"73","author":"H Okamoto","year":"1992","unstructured":"Okamoto H, Sugiuama Y, Okada SI, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M: Typing hepatitis C virus bt polyme rase chain reaction with type specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673\u2013679, 1992","journal-title":"J Gen Virol"},{"key":"294547_CR14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/0016-5085(83)90369-4","volume":"84","author":"E Baravalle","year":"1993","unstructured":"Baravalle E, Prieto J: Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease. Gastroenterology 84:1483\u20131491, 1993","journal-title":"Gastroenterology"},{"key":"294547_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(85)90287-9","volume":"1","author":"GH Elder","year":"1985","unstructured":"Elder GH, Urquhart AJ, De Salamanca RE, Munoz JJ, Bonk-ovsky HL: Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet 1:229\u2013232, 1985","journal-title":"Lancet"},{"key":"294547_CR16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/hep.1840100319","volume":"10","author":"HL Bonkovsky","year":"1989","unstructured":"Bonkovsky HL: Mechanism of iron potentiation of hepatic uroporphyria: Studies in cultured chick embryo liver cells. Hepatology 10:354\u2013364, 1989","journal-title":"Hepatology"},{"key":"294547_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1053\/jhep.1996.v24.pm0008855176","volume":"24","author":"T Ponard","year":"1996","unstructured":"Ponard T, Leroy V, Cohard M, Thevonot T, Mathurin P, Opolon P, Zarski JP: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration. Hepatology 24:778\u2013789, 1996","journal-title":"Hepatology"},{"key":"294547_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJM199701303360507","volume":"336","author":"JH Hoofnagle","year":"1997","unstructured":"Hoofnagle JH, DiBisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 336:347\u2013356, 1997","journal-title":"N Engl J Med"},{"key":"294547_CR19","doi-asserted-by":"crossref","first-page":"115S","DOI":"10.1007\/BF02087886","volume":"41","author":"G Saracco","year":"1996","unstructured":"Saracco G, Rizzetto M: Predictors of response to interferon therapy. Dig Dis Sci 41:115S\u2013120S, 1996","journal-title":"Dig Dis Sci"},{"key":"294547_CR20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/hep.1840200605","volume":"20","author":"K Mahaney","year":"1994","unstructured":"Mahaney K, Tedeschi V, Maertens G, Di Bisceglie AM, Vergalla J, Hoofnagle JH, Sallie R: Genotype analysis of hepatitis C in American patients. Hepatology 20:1405\u20131411, 1994","journal-title":"Hepatology"},{"key":"294547_CR21","doi-asserted-by":"crossref","first-page":"486A","DOI":"10.1002\/hep.510240341","volume":"24","author":"HL Bonkovsky","year":"1996","unstructured":"Bonkovsky HL, Poh-Fitzpatrick M, Tattrie C, DiBiscglie A: Porphyria cutanea tarda and hepatitis C in the USA. Hepatology 24:486A, 1996","journal-title":"Hepatology"},{"key":"294547_CR22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2230.1991.tb00369.x","volume":"16","author":"D Adjarove","year":"1991","unstructured":"Adjarove D, Kerimova M: Effective control of patients with porphyria cutanea tarda by measuring plasma uroporphyrin. Clin Exp Dermatol 16:254\u2013257, 1991","journal-title":"Clin Exp Dermatol"},{"key":"294547_CR23","first-page":"107","volume":"100","author":"O Lundvall","year":"1982","unstructured":"Lundvall O: Phlebotomy treatment of porphyria cutanea tarda. Acta Derm Venereol Suppl (Stockh) 100:107\u2013118, 1982","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"294547_CR24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0168-8278(94)80017-0","volume":"20","author":"DH Van Thiel","year":"1994","unstructured":"Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS: Response to interferon alfa therapy is influenced by the iron content of liver. J Hepatol 20:410\u2013415, 1994","journal-title":"J Hepatol"},{"key":"294547_CR25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3181\/00379727-141-36868","volume":"141","author":"W Braun","year":"1972","unstructured":"Braun W, Levy HB: Interferon preparations as modifiers of immune responses. Proc Soc Exp Biol Med 141:769\u2013773, 1972","journal-title":"Proc Soc Exp Biol Med"},{"key":"294547_CR26","first-page":"59","volume-title":"Mechanisms of Interferon Actions","author":"HM Johnson","year":"1987","unstructured":"Johnson HM: Interferon-mediated modulation of immune system. InMechanisms of Interferon Actions, Volume 2. LM Pfeffer (ed). Boca Raton, Florida, CRC Pre ss, 1987, pp 59\u201377"},{"key":"294547_CR27","doi-asserted-by":"publisher","first-page":"155A","DOI":"10.1016\/S0168-8278(96)80024-9","volume":"24","author":"ZY Ohkawa","year":"1996","unstructured":"Ohkawa ZY, Takahashi H, Aizawa Y, Watanabe F, Toda G: Increased serum level of interleukin-1 receptor antagonist cor-relates with efficacy of interferon therapy and HCV-RNA level in chronic hepatitis C. Hepatology 24:155A, 1996","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018854906444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018854906444\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018854906444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T02:44:11Z","timestamp":1752461051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018854906444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["294547"],"URL":"https:\/\/doi.org\/10.1023\/a:1018854906444","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}